Prostate cancer screening compares favourably to screening for breast cancer in identifying significant cancers, reducing mortality and avoiding unnecessary harms, says new research.

Prostate cancer screening compares favorably to screening for breast cancer in identifying significant cancers, reducing ...

Prostate cancer screening saves many more lives than earlier studies suggested, research shows. The results from the longest-running European trial show one life saved for every six men diagnosed, a ...

Urologists, radiologists and pathologists from Europe and the US agreed an “expert consensus statement” on prostate cancer ...

Millions of men could benefit from a faster 15-minute prostate cancer scan that paves the way to a national screening programme. The new MRI scan takes half the time of the current one and costs half ...

Prostate cancer is the most commonly diagnosed cancer in the UK. But screening is not universal, and charities are divided over whether it should be extended. What do those living with the disease ...

Prostate-cancer screening based on prostate-specific antigen (PSA) levels in the blood was introduced—and readily adopted—in the United States around the late 1980s. But this screening method, in ...

It’s important to follow guidance on prostate-specific antigen screening that maximizes benefits and minimizes potential harms such as overdiagnosis and overtreatment.

A prostate cancer committee has been accused of exaggerating the risks of screening. Advisers to Wes Streeting, the Health ...

Add Yahoo as a preferred source to see more of our stories on Google. Prostate cancer is the most common cancer in men, with about 67,000 diagnoses each year in the UK Prostate cancer screening should ...

EAU26: prostate cancer screening compares favourably compared to breast cancer in identifying significant cancers and reducing mortality.